Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Leukemia 29Hematologic Neoplasms 23Myelodysplastic Syndromes 18Lymphoma 16Neoplasms 15Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12Lymphoma, Non-Hodgkin 9Leukemia, Lymphocytic, Chronic, B-Cell 7Graft vs Host Disease 7Neoplasms by Site 6Neoplasms by Histologic Type 6Multiple Myeloma 6Anemia, Refractory, with Excess of Blasts 6Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms, Plasma Cell 5Neoplasm, Residual 5Leukemia, Biphenotypic, Acute 5Infections 5Primary Myelofibrosis 4Lymphoproliferative Disorders 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Glioma 4Congenital Abnormalities 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Opportunistic Infections × Other hematologic neoplasm × Clear all
NCT02942173 2023-03-16

CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 2/3 Completed
150 enrolled
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Opportunistic Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡